PIAZZA, ROCCO GIOVANNI
PIAZZA, ROCCO GIOVANNI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses
2000 Legeai Mallet, L; Rossi, A; Benoist Lasselin, C; Piazza, R; Mallet, J; Delezoide, A; Munnich, A; Bonaventure, J; Zylberberg, L
Il connettivo (collageno e proteoglicani)
2002 Cetta, G; Piazza, R
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias
2003 Rossi, A; Cetta, G; Piazza, R; Bonaventure, J; Steinmann, B; Superti Furga, A
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR)
2003 Piazza, R; Magistroni, V; Tornaghi, L; Andreoni, F; Bungaro, S; Cazzaniga, G; Biondi, A; Pogliani, E; Varella Garcia, M; Corneo, G; GAMBACORTI PASSERINI, C
Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels
2003 GAMBACORTI PASSERINI, C; Piazza, R; D'Incalci, M
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
2003 GAMBACORTI PASSERINI, C; Gunby, R; Piazza, R; Galietta, A; Rostagno, R; Scapozza, L
SNP MINING BY NANOGEN DEVICE: A SENSITIVE TOOL FOR THE IDENTIFICATION OF BCR/ABL MUTATIONS IN PH+ PATIENTS
2004 Corradi, B; Piazza, R; Monn, K; Masera, G; GAMBACORTI PASSERINI, C; Biondi, A; Cazzaniga, G
Development of c-Kit-expressing Small-Cell lung Cancer in a Chronic Myeloid Leukemia Patient During Imatinib Treatment
2004 GAMBACORTI PASSERINI, C; Piazza, R; Tornaghi, L; Pilotti, S; Pogliani, E
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment
2004 Cazzaniga, G; Corradi, B; Piazza, R; Soverini, S; Martinelli, G; GAMBACORTI PASSERINI, C; Biondi, A
NPM/ALK co-localizes with, and phosphorylates PSF and other RNA-binding proteins
2005 Galietta, A; Gunby, R; Stano, P; Tucker, P; Carniti, C; Ruchatz, H; Piazza, R; Huang, C; Tartari, C; Puttini, M; Pulford, K; Colombo, E; Bachi, A; GAMBACORTI PASSERINI, C
Autoimmune hepatitis presenting as imatinib toxicity: description of a case and of therapeutic alternatives
2005 Franceschino, A; Tornaghi, L; Piazza, R; Pogliani, E; GAMBACORTI PASSERINI, C
ABL INHIBITOR BMS354825 BINDING MODE IN ABELSON KINASE REVEALED BY MOLECULAR DOCKING STUDIES
2005 GAMBACORTI PASSERINI, C; Piazza, R; Gasser, M; Ahmed, S; Scapozza, L
SIGNIFICANT REDUCTION IN FASTING BLOOD GLUCOSE IN NONDIABETIC PH+ CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB MESYLATE
2005 Tornaghi, L; Franceschino, A; Piazza, R; Gnessi, L; Pogliani, E; GAMBACORTI PASSERINI, C
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients
2005 Piazza, R; Magistroni, V; Andreoni, F; Franceschino, A; Tornaghi, L; Varella Garcia, M; Bungaro, S; Colnaghi, F; Corneo, G; Pogliani, E; GAMBACORTI PASSERINI, C
Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by leguay et al
2005 Piazza, R; Magistroni, V; Franceschino, A; GAMBACORTI PASSERINI, C
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype
2005 Forlino, A; Piazza, R; Tiveron, C; Della Torre, S; Tatangelo, L; Bonafe, L; Gualeni, B; Romano, A; Pecora, F; Superti Furga, A; Cetta, G; Rossi, A
Evidence for D276G and L364I Bcr-Abl mutations in Ph plus leukaemic cells obtained from patients resistant to Imatinib
2005 Piazza, R; Magistroni, V; Gasser, M; Andreoni, F; Galietta, A; Scapozza, L; GAMBACORTI PASSERINI, C
Bim promoter is highly methylated in malignant lymphoid cell lines, leading to downregulation of Bim expression and protection from apoptosis
2005 Piazza, R; Magistroni, V; Andreoni, F; Franceschino, A; GAMBACORTI PASSERINI, C
BIM promoter is epigenetically silenced in malignant lymphoid cells, leading to downregulation of BIM expression and protection from apoptosis
2006 Magistroni, V; Piazza, R; Brambilla, C; Andreoni, F; Franceschino, A; Collini, P; GAMBACORTI PASSERINI, C
HOMOZYGOSITY FOR JAK2V617F IDENTIFIES MPD PATIENTS WITH A MORE SYMPTOMATIC DISEASE A RETROSPECTIVE STUDY ON 989 PATIENTS FROM THE GIMEMA-MPD WORKING PARTY
2006 Vannucchi, A; Barosi, G; Rambaldi, A; Marchioli, M; Barbui, T; Antonioli, E; Guglielmelli, P; Longo, G; Bosi, A; Marchetti, M; Destefano, V; Leone, G; Alimena, G; Foà, R; Ruggeri, M; Rodeghiero, F; Specchia, G; Liso, V; Gerli, G; Cattaneo, M; Piazza, R; Pogliani, E; Carraro, M; Rossi, E; Tieghi, A; Gugliotta, L; Marfisi, M